Benitec Biopharma stockholders elect directors and ratify auditor at 2025 annual meeting

Benitec Biopharma Inc.

22,327,761 shares present (85.06% of outstanding); all proposals passed.
Directors Dr. Jerel Banks (22,150,169 for) and Megan Boston (21,693,741 for) elected.
Ratification of independent auditor approved: 22,252,834 for, 4,787 against.
Advisory vote on executive compensation passed with 17,239,339 for, 4,939,686 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.